{"entity":{"type":"insider","cik":"0001574261","url":"/insider/0001574261","json_url":"/insider/0001574261.json","name":"Paggiarino Dario A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":6,"first":"2023-12-06","last":"2024-01-30","span_basis":"filed_date"},"name_variants":[{"name":"Paggiarino Dario A.","source":"filing","n_filings":6,"first_seen":"2023-12-06","last_seen":"2024-01-30"}],"transactions":[{"id":2046979,"accession":"0001562180-24-000808","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-24-000808","line_url":"/filing/0001562180-24-000808","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001574261","owner_name":"Paggiarino Dario A.","owner_display_name":"Paggiarino Dario A.","owner_url":"/insider/0001574261","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49325.0,"shares_display":"49,325","price_per_share":25.657150866700455,"price_display":"25.66","price_state":"stated","total_value":1265538.9665,"total_display":"1,265,538.97","total_whole":"1,265,539","shares_owned_after":36505.0,"shares_owned_after_display":"36,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-26","filed_date":"2024-01-30","scope":"insider","n_lines":3},{"id":2252956,"accession":"0001562180-24-000784","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-24-000784","line_url":"/filing/0001562180-24-000784","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001574261","owner_name":"Paggiarino Dario A.","owner_display_name":"Paggiarino Dario A.","owner_url":"/insider/0001574261","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","total_whole":"15,000","shares_owned_after":36805.0,"shares_owned_after_display":"36,805","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-25","filed_date":"2024-01-29","scope":"insider","n_lines":2},{"id":2317736,"accession":"0001562180-24-000637","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001562180-24-000637","line_url":"/filing/0001562180-24-000637","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001574261","owner_name":"Paggiarino Dario A.","owner_display_name":"Paggiarino Dario A.","owner_url":"/insider/0001574261","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11251.0,"shares_display":"11,251","price_per_share":25.01246427873078,"price_display":"25.01","price_state":"stated","total_value":281415.2356,"total_display":"281,415.24","total_whole":"281,415","shares_owned_after":36505.0,"shares_owned_after_display":"36,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-24","filed_date":"2024-01-25","scope":"insider","n_lines":2},{"id":2317716,"accession":"0001562180-24-000637","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-24-000637","line_url":"/filing/0001562180-24-000637","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001574261","owner_name":"Paggiarino Dario A.","owner_display_name":"Paggiarino Dario A.","owner_url":"/insider/0001574261","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5135.0,"shares_display":"5,135","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":128375.0,"total_display":"128,375.00","total_whole":"128,375","shares_owned_after":36505.0,"shares_owned_after_display":"36,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-23","filed_date":"2024-01-25","scope":"insider","n_lines":2},{"id":3184724,"accession":"0001562180-24-000414","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-000414","line_url":"/filing/0001562180-24-000414#line-2","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001574261","owner_name":"Paggiarino Dario A.","owner_display_name":"Paggiarino Dario A.","owner_url":"/insider/0001574261","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22913.0,"shares_display":"22,913","price_per_share":21.1288,"price_display":"21.13","price_state":"stated","total_value":484124.1944,"total_display":"484,124.19","total_whole":"484,124","shares_owned_after":36505.0,"shares_owned_after_display":"36,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-08","filed_date":"2024-01-10","scope":"insider"},{"id":8180863,"accession":"0001562180-23-008415","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-23-008415","line_url":"/filing/0001562180-23-008415#line-2","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001574261","owner_name":"Paggiarino Dario A.","owner_display_name":"Paggiarino Dario A.","owner_url":"/insider/0001574261","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1458.0,"shares_display":"1,458","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":29160.0,"total_display":"29,160.00","total_whole":"29,160","shares_owned_after":25707.0,"shares_owned_after_display":"25,707","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-13","filed_date":"2023-12-15","scope":"insider"},{"id":7978441,"accession":"0001562180-23-008171","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-23-008171","line_url":"/filing/0001562180-23-008171#line-2","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001574261","owner_name":"Paggiarino Dario A.","owner_display_name":"Paggiarino Dario A.","owner_url":"/insider/0001574261","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30625.0,"shares_display":"30,625","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":673750.0,"total_display":"673,750.00","total_whole":"673,750","shares_owned_after":25707.0,"shares_owned_after_display":"25,707","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-04","filed_date":"2023-12-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001314102","name":"EyePoint Pharmaceuticals, Inc.","url":"/issuer/0001314102","role":"Officer (Chief Medical Officer)","n_filings":6,"first_seen":"2023-12-06","last_seen":"2024-01-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001574261","retrieved_at":"2026-08-23T02:14:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}